LIMK2 (LIM domain kinase 2)

2003-11-01  

Identity

HGNC
LOCATION
22q12.2
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 3985
MIM: 601988
HGNC: 6614
Ensembl: ENSG00000182541

Variants:

dbSNP: 3985
ClinVar: 3985
TCGA: ENSG00000182541
COSMIC: LIMK2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000182541ENST00000331728P53671
ENSG00000182541ENST00000331728A0A024R1H6
ENSG00000182541ENST00000333611P53671
ENSG00000182541ENST00000333611A0A024R1M2
ENSG00000182541ENST00000340552P53671
ENSG00000182541ENST00000406516B5MC51
ENSG00000182541ENST00000425203C9JK61

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Axon guidanceKEGGko04360
Regulation of actin cytoskeletonKEGGko04810
Axon guidanceKEGGhsa04360
Regulation of actin cytoskeletonKEGGhsa04810
Fc gamma R-mediated phagocytosisKEGGko04666
Fc gamma R-mediated phagocytosisKEGGhsa04666
Signal TransductionREACTOMER-HSA-162582
Signaling by Rho GTPasesREACTOMER-HSA-194315
RHO GTPase EffectorsREACTOMER-HSA-195258
RHO GTPases Activate ROCKsREACTOMER-HSA-5627117
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
Semaphorin interactionsREACTOMER-HSA-373755
Sema4D in semaphorin signalingREACTOMER-HSA-400685
Sema4D induced cell migration and growth-cone collapseREACTOMER-HSA-416572
EPH-Ephrin signalingREACTOMER-HSA-2682334
EPHB-mediated forward signalingREACTOMER-HSA-3928662

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
352735912022LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma.5
352735912022LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma.5
329318872021Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo.12
339773982021Involvement of LIMK2 in actin cytoskeleton remodeling during the definitive endoderm differentiation.3
346865032021The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.1
329318872021Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo.12
339773982021Involvement of LIMK2 in actin cytoskeleton remodeling during the definitive endoderm differentiation.3
346865032021The Diagnostic and Prognostic Value of LIMK1/2: A Pan-Cancer Analysis.1
316410312020Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.11
316410312020Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.11
300069722019LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.16
305945632019LIMK2-1 is a Hominidae-Specific Isoform of LIMK2 Expressed in Central Nervous System and Associated with Intellectual Disability.5
312779402019GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway.13
316957592019NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.25
300069722019LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.16

Citation

Dessen P

LIMK2 (LIM domain kinase 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-11-01

Online version: http://atlasgeneticsoncology.org/gene/41160/deep-insight-explorer/haematological-explorer/js/web-card-_common.js